Net costs of breast cancer care in a health promotion entity of Colombia
Introduction: The estimation of costs associated with cancer care is essential for the implementation of technologies, programs, and policies aimed at prevention and treatment. Objective: To estimate the average annual net costs of breast cancer care for each phase of care and the average annual net...
- Autores:
-
Urrego Novoa, José Ricardo
hincapie, ana
Díaz, Jorge
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2024
- Institución:
- Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
- Repositorio:
- Repositorio Institucional UDCA
- Idioma:
- eng
- OAI Identifier:
- oai:repository.udca.edu.co:11158/6618
- Acceso en línea:
- https://repository.udca.edu.co/handle/11158/6618
https://doi.org/10.15446/revfacmed.v72n3.112282.
https://repository.udca.edu.co/
- Palabra clave:
- 610 - Medicina y salud
Prevención de Enfermedades
Costos de la Atención en Salud
Neoplasias
Cáncer
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode.es
| Summary: | Introduction: The estimation of costs associated with cancer care is essential for the implementation of technologies, programs, and policies aimed at prevention and treatment. Objective: To estimate the average annual net costs of breast cancer care for each phase of care and the average annual net cost per patient in each phase of care of patients under the contributory regime subscribed to a health promotion entity (EPS by its Spanish acronym) in Colombia. Material and methods. Retrospective matched case-control study conducted using data from 4 278 patients served between January 1, 2010, and December 31, 2016, by an EPS with a presence throughout Colombia (713 cases with breast cancer and 3 565 controls). Net costs were estimated utilizing the net cost method and were expressed in constant 2023 US dollars for each phase of care (initial, continuing, and last year of life). Results: The average annual net costs of breast cancer care for the initial, continuing, and last year of life phases were 24 431 719.80 USD, 27 325 443.38 USD, and 6 786 347.62 USD, respectively. The average annual net costs per patient for these same phases were 50 583.27 USD, 46 710.16 USD, and 147 529.30 USD, respectively. Conclusion: The average annual net costs of breast cancer care were higher in the continuing phase, followed by the initial and last year of life phases. In turn, the average annual net cost per patient was higher in the last year of life phase, followed by the initial phase. |
|---|
